KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Cash & Current Investments (2016 - 2025)

CareDx's Cash & Current Investments history spans 13 years, with the latest figure at $177.2 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments fell 32.01% year-over-year to $177.2 million; the TTM value through Dec 2025 reached $177.2 million, down 32.01%, while the annual FY2025 figure was $177.2 million, 32.01% down from the prior year.
  • Cash & Current Investments for Q4 2025 was $177.2 million at CareDx, down from $194.2 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $374.3 million in Q1 2021 and bottomed at $177.2 million in Q4 2025.
  • The 5-year median for Cash & Current Investments is $275.4 million (2023), against an average of $273.6 million.
  • The largest annual shift saw Cash & Current Investments soared 1062.71% in 2021 before it crashed 32.01% in 2025.
  • A 5-year view of Cash & Current Investments shows it stood at $348.5 million in 2021, then fell by 15.9% to $293.1 million in 2022, then decreased by 19.68% to $235.4 million in 2023, then rose by 10.72% to $260.7 million in 2024, then crashed by 32.01% to $177.2 million in 2025.
  • Per Business Quant, the three most recent readings for CDNA's Cash & Current Investments are $177.2 million (Q4 2025), $194.2 million (Q3 2025), and $186.3 million (Q2 2025).